16:06 · 29 July 2026

Double-digit gains after earnings in Europe: Electrolux, Alten, Hexagon

Wednesday’s session is bringing double-digit share price gains for three European companies. In each case, the catalyst was a clear beat versus prior expectations, although the quality of the positive signals varies.

Electrolux was up about 20% after almost doubling operating profit forecasts.

  • Operating profit excluding one-off items rose to SEK 1.20bn versus SEK 617m expected, and organic sales increased by 2%.
  • The result shows the effects of the cost-saving program, which improved performance by SEK 1.4bn.
  • However, this does not come entirely from an improvement in the company’s business model, because about SEK 484m came from a refund of U.S. tariffs and a change to the healthcare benefits program.
  • The most important and lasting fundamental signal remains cost optimization and free cash flow, rather than a rebound in demand in North America, where organic sales fell by 3%.

Chart: ELUXB.SE (D1)

 

Despite the large rise, it is hard to see long-term price growth. Looking at the chart optimistically, one can see a move away from the lower boundary of the downward trend channel. Source: xStation5

Alten was up about 15% after a clear upgrade to its 2026 outlook.

  • Second-quarter sales increased organically by 3.2%.
  • The company raised its full-year expectations from around 0% to growth of 1.4 to 1.8%.
  • Operating margin is expected to reach around 9%, up from 8.5% in 2025.
  • The improvement is driven primarily by aerospace, defense, security, and rail.
  • This is a classic case of repricing a previously very low base-case scenario, followed by a sharp upward correction in expectations.

Chart: ATE.FR (D1)

 

Recent gains show a clear breakout from the long-term downward channel. The current level may be a good base for further gains, if the company manages to keep improving results. Source: xStation5

Hexagon was up more than 10% after an excellent Q2 2026 result.

  • Organic growth was 12%, nearly twice the expected 6.4%.
  • Revenue reached EUR 1.05bn versus a consensus of EUR 1.01bn.
  • Adjusted EBIT was EUR 272m versus EUR 261m expected.
  • The catalyst was very strong demand from the aerospace and defense industry. Additional support comes from a high order backlog and a cost consolidation and restructuring program completed ahead of schedule.

Chart: HEXAB.SE (D1)

 

The strong results show the company’s strength and support valuations, but the price still remains in the lower range of a broad consolidation. Source: xStation5

4 September 2026, 09:45

Morning Wrap: Can NFP Confirm Waller’s Dovish Turn?

3 September 2026, 22:08

Daily Summary: Nasdaq, Gold, and Bitcoin benefit from lower bond yields (03.09.2026)

3 September 2026, 19:03

US Open: Dovish Waller supports the stock market (03.09.2026)

3 September 2026, 14:00

Broadcom Delivers Record Results. The Market Is Already Looking Much Further Ahead

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.